-
1
-
-
0030043446
-
Cancer Statistics, 1996
-
Parker S.L., Tong T., Bolden S., Wingo P.A. Cancer Statistics, 1996. CA Cancer J. Clin. 46:1996;5-28.
-
(1996)
CA Cancer J. Clin.
, vol.46
, pp. 5-28
-
-
Parker, S.L.1
Tong, T.2
Bolden, S.3
Wingo, P.A.4
-
2
-
-
0028202803
-
Radiolabeled antibody imaging of patients with potentially resectable colorectal adenocarcinoma
-
Weiner G.J., Kahn D., Jochimsen P.R., Bevering C.G., Kisker A. Radiolabeled antibody imaging of patients with potentially resectable colorectal adenocarcinoma. Cancer Invest. 12:1994;111-120.
-
(1994)
Cancer Invest.
, vol.12
, pp. 111-120
-
-
Weiner, G.J.1
Kahn, D.2
Jochimsen, P.R.3
Bevering, C.G.4
Kisker, A.5
-
3
-
-
0028020090
-
Radioimmunoscintigraphy with (111)indium labeled CYT-356 for the detection of occult prostate cancer recurrence
-
Kahn D., Williams R.D., Seldin D.W., Libertino J.A., Hirschhorn M., Dreicer R., Weiner G.J., Bushnell D., Gulfo J. Radioimmunoscintigraphy with (111)indium labeled CYT-356 for the detection of occult prostate cancer recurrence. J. Urol. 152:1994;1490-1495.
-
(1994)
J. Urol.
, vol.152
, pp. 1490-1495
-
-
Kahn, D.1
Williams, R.D.2
Seldin, D.W.3
Libertino, J.A.4
Hirschhorn, M.5
Dreicer, R.6
Weiner, G.J.7
Bushnell, D.8
Gulfo, J.9
-
4
-
-
0028127304
-
Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma
-
Maloney D.G., Liles T.M., Czerwinski D.K., Waldichuk C., Rosenberg J., Grillolopez A., Levy R. Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. Blood. 84:1994;2457-2466.
-
(1994)
Blood
, vol.84
, pp. 2457-2466
-
-
Maloney, D.G.1
Liles, T.M.2
Czerwinski, D.K.3
Waldichuk, C.4
Rosenberg, J.5
Grillolopez, A.6
Levy, R.7
-
5
-
-
0028224082
-
Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' colorectal carcinoma
-
Riethmuller G., Schneider-Gadicke E., Schlimok G., Schmiegel W., Raab R., Hoffken K., Gruber R., Pichlmaier H., Hirche H., Pichlmaier R. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' colorectal carcinoma. Lancet. 343:1994;1177-1183.
-
(1994)
Lancet
, vol.343
, pp. 1177-1183
-
-
Riethmuller, G.1
Schneider-Gadicke, E.2
Schlimok, G.3
Schmiegel, W.4
Raab, R.5
Hoffken, K.6
Gruber, R.7
Pichlmaier, H.8
Hirche, H.9
Pichlmaier, R.10
-
6
-
-
0025890304
-
A novel prostate carcinoma-associated glycoprotein complex (PAC) recognized by monoclonal antibody TURP-27
-
Wright G.L., Beckett M.L., Lipford G.B., Haley C.L., Schellhammer P.F. A novel prostate carcinoma-associated glycoprotein complex (PAC) recognized by monoclonal antibody TURP-27. Int. J. Cancer. 47:1991;717-725.
-
(1991)
Int. J. Cancer
, vol.47
, pp. 717-725
-
-
Wright, G.L.1
Beckett, M.L.2
Lipford, G.B.3
Haley, C.L.4
Schellhammer, P.F.5
-
7
-
-
0027327531
-
PR1, a monoclonal antibody that reacts with an antigen on the surface of normal and malignant prostate cells
-
Pastan I., Lovelace E., Rutherford A.V., Kunwar S., Willingham M.C., Peehl D.M. PR1, a monoclonal antibody that reacts with an antigen on the surface of normal and malignant prostate cells. J. Natl. Cancer Inst. 85:1993;1149-1154.
-
(1993)
J. Natl. Cancer Inst.
, vol.85
, pp. 1149-1154
-
-
Pastan, I.1
Lovelace, E.2
Rutherford, A.V.3
Kunwar, S.4
Willingham, M.C.5
Peehl, D.M.6
-
8
-
-
0028290221
-
Tumor associated glycoprotein-72 is highly expressed in prostatic adenocarcinomas
-
Myers R.B., Meredith R., Schlom J., LoBuglio A.F., Bueschen A.J., Wheeler R.H., Stockard C.R., Grizzle W.E. Tumor associated glycoprotein-72 is highly expressed in prostatic adenocarcinomas. J. Urol. 152:1994;243-246.
-
(1994)
J. Urol.
, vol.152
, pp. 243-246
-
-
Myers, R.B.1
Meredith, R.2
Schlom, J.3
Lobuglio, A.F.4
Bueschen, A.J.5
Wheeler, R.H.6
Stockard, C.R.7
Grizzle, W.E.8
-
9
-
-
0023547004
-
Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients
-
Horoszewicz J.S., Kawinski E., Murphy G.P. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res. 7:1987;927-935.
-
(1987)
Anticancer Res.
, vol.7
, pp. 927-935
-
-
Horoszewicz, J.S.1
Kawinski, E.2
Murphy, G.P.3
-
10
-
-
0025912619
-
Immunoscintigraphy of prostate cancer: Preliminary results with (111)In-labeled monoclonal antibody 7E11-C5.3 (CYT-356)
-
Wynant G.E., Murphy G.P., Horoszewicz J.S., Neal C.E., Collier B.D., Mitchell E., Purnell G., Tyson I., Heal A., Abdel N.H. Immunoscintigraphy of prostate cancer: preliminary results with (111)In-labeled monoclonal antibody 7E11-C5.3 (CYT-356). Prostate. 18:1991;229-241.
-
(1991)
Prostate
, vol.18
, pp. 229-241
-
-
Wynant, G.E.1
Murphy, G.P.2
Horoszewicz, J.S.3
Neal, C.E.4
Collier, B.D.5
Mitchell, E.6
Purnell, G.7
Tyson, I.8
Heal, A.9
Abdel, N.H.10
-
11
-
-
0028927693
-
Expression of cellular adhesion molecules on human prostate tumor cell lines
-
Rokhlin O.W., Cohen M.B. Expression of cellular adhesion molecules on human prostate tumor cell lines. Prostate. 26:1995;205-212.
-
(1995)
Prostate
, vol.26
, pp. 205-212
-
-
Rokhlin, O.W.1
Cohen, M.B.2
-
12
-
-
0028804782
-
Differential sensitivity of human prostatic cancer cell lines to the effects of protein kinase and phosphatase inhibitors
-
Rokhlin O.W., Cohen M.B. Differential sensitivity of human prostatic cancer cell lines to the effects of protein kinase and phosphatase inhibitors. Cancer Lett. 98:1995;103-110.
-
(1995)
Cancer Lett.
, vol.98
, pp. 103-110
-
-
Rokhlin, O.W.1
Cohen, M.B.2
-
13
-
-
0030272159
-
Soluble forms of CD44 and CD54 (ICAM-1) cellular adhesion molecules are released by human prostatic cancer cell lines
-
Rokhlin O.W., Cohen M.B. Soluble forms of CD44 and CD54 (ICAM-1) cellular adhesion molecules are released by human prostatic cancer cell lines. Cancer Lett. 107:1996;29-35.
-
(1996)
Cancer Lett.
, vol.107
, pp. 29-35
-
-
Rokhlin, O.W.1
Cohen, M.B.2
-
14
-
-
14444279883
-
Fas-mediated apoptosis in human prostatic carcinoma cell lines
-
Rokhlin O.W., Bishop G.A., Hostager B.S., Waldschmidt T.J., Sidorenko S.P., Pavloff N., Kiefer M.C., Umansky S.R., Glover R.A., Cohen M.B. Fas-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res. 57:1997;1758-1768.
-
(1997)
Cancer Res.
, vol.57
, pp. 1758-1768
-
-
Rokhlin, O.W.1
Bishop, G.A.2
Hostager, B.S.3
Waldschmidt, T.J.4
Sidorenko, S.P.5
Pavloff, N.6
Kiefer, M.C.7
Umansky, S.R.8
Glover, R.A.9
Cohen, M.B.10
-
15
-
-
0029035687
-
Differential expression of endoglin on fetal and adult hematopoietic cells in human bone marrow
-
Rokhlin O.W., Cohen M.B., Kubagawa H., Letarte M., Cooper M.D. Differential expression of endoglin on fetal and adult hematopoietic cells in human bone marrow. J. Immunol. 154:1995;4456-4465.
-
(1995)
J. Immunol.
, vol.154
, pp. 4456-4465
-
-
Rokhlin, O.W.1
Cohen, M.B.2
Kubagawa, H.3
Letarte, M.4
Cooper, M.D.5
|